Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver transplantation.

T E Starzl

    The Johns Hopkins Medical Journal
    |September 1, 1978
    PubMed
    Summary

    Liver transplant survival rates improved significantly due to refined surgical techniques and patient management. Early challenges like biliary issues and vascular complications were addressed, leading to better patient outcomes and projected 50% one-year survival.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease.

    The New England journal of medicine·1992
    Same author

    HLA matching effect in liver transplantation.

    Transplantation proceedings·1992
    Same author

    Posttransplant donor-specific T-lymphocytotoxic antibody in liver transplant patients with a positive crossmatch.

    Transplantation proceedings·1992
    Same author

    Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium.

    Transplantation proceedings·1992
    Same author

    FK 506: an effective immunosuppressant for islet xenotransplantation.

    Transplantation proceedings·1992
    Same author

    Characterization and epitope mapping of human monoclonal antibodies to PDC-E2, the immunodominant autoantigen of primary biliary cirrhosis.

    Journal of autoimmunity·1992

    Area of Science:

    • Hepatobiliary surgery
    • Transplantation immunology
    • Gastroenterology

    Background:

    • Orthotopic liver homografts were performed on 111 patients between March 1963 and June 1976.
    • Congenital biliary atresia was the most common diagnosis, followed by chronic aggressive hepatitis, Laennec's cirrhosis, and primary hepatic malignancy.

    Purpose of the Study:

    • To analyze long-term outcomes of orthotopic liver transplantation.
    • To identify common causes of graft failure and refine surgical and postoperative management strategies.

    Main Methods:

    • Retrospective clinical-pathologic correlation of 111 liver transplant recipients.
    • Analysis of failure causes, including technical issues, vascular complications, and graft quality.
    • Implementation of improved intraoperative and postoperative management, focusing on biliary drainage and microvascular techniques.

    Main Results:

    • 28% of the initial 111 patients survived at least one year; 15 remain alive with follow-up up to 8.5 years.
    • Technical misadventures (biliary tract problems, vascular thromboses) and ischemic liver damage were primary causes of failure.
    • Rejection was a less significant factor than anticipated.
    • A subsequent series of 30 patients (July 1976-December 1977) showed 15 survivors (50%) at 6-22 months post-transplant.

    Conclusions:

    • Improvements in surgical techniques and patient management have significantly enhanced liver transplant outcomes.
    • Focusing on biliary tract drainage and microvascular techniques has reduced complications.
    • A projected one-year survival rate of 50% indicates a greatly improved outlook for liver transplant recipients.

    Related Experiment Videos